Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor

Hypertension (HTN), clinically defined as systolic blood pressure (SBP) > 140 mmHg, or diastolic blood pressure (DBP) > 90 mmHg, or both affects approximately 1.28 billion people aged between 30 and 79 years globally [1, 2]. The overall global prevalence of hypertension in 2000 was estimated a...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng, Hoh-Boon, Ibrahim, Fananta, Maamor, Nur Hasnah
Format: Article
Language:en
Published: Faculty of Medicine 2024
Subjects:
Online Access:https://ir.uitm.edu.my/id/eprint/101434/1/101434.pdf
https://ir.uitm.edu.my/id/eprint/101434/
https://jchs-medicine.uitm.edu.my/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1833322022955909120
author Peng, Hoh-Boon
Ibrahim, Fananta
Maamor, Nur Hasnah
author_facet Peng, Hoh-Boon
Ibrahim, Fananta
Maamor, Nur Hasnah
author_sort Peng, Hoh-Boon
building Tun Abdul Razak Library
collection Institutional Repository
content_provider Universiti Teknologi Mara
content_source UiTM Institutional Repository
continent Asia
country Malaysia
description Hypertension (HTN), clinically defined as systolic blood pressure (SBP) > 140 mmHg, or diastolic blood pressure (DBP) > 90 mmHg, or both affects approximately 1.28 billion people aged between 30 and 79 years globally [1, 2]. The overall global prevalence of hypertension in 2000 was estimated at 26.4% [3]. In the 2015 estimates, however, the average prevalence had increased to 32.3% in low- and middle-income countries, with prevalence estimates of 39.1% in the Latin American and Caribbean regions [4]. Interestingly, the prevalence of hypertension was also reportedly the highest in populations from the upper middle-income countries (37.8%) and lowest in populations from low-income countries (23.1%) [4]. In addition, prevalence estimates were higher in those aged 65 years and above compared with that in those below 65 years of age. No significant gender-difference in hypertension prevalence was noted, but persons with no formal education (49.0%), or who were overweight/obese (46.4%), and urban settlers (32.7%) were more likely to be hypertensive compared with those who were educated, normal weight, and living in rural areas [4]. In Malaysia, the 2023 National Health and Morbidity Survey (NHMS, 2023) revealed that approximately one in three adults in Malaysia have hypertension [5].
format Article
id my.uitm.ir-101434
institution Universiti Teknologi Mara
language en
publishDate 2024
publisher Faculty of Medicine
record_format eprints
spelling my.uitm.ir-1014342024-09-04T08:13:24Z https://ir.uitm.edu.my/id/eprint/101434/ Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor jchs Peng, Hoh-Boon Ibrahim, Fananta Maamor, Nur Hasnah Hypertension Hypertension (HTN), clinically defined as systolic blood pressure (SBP) > 140 mmHg, or diastolic blood pressure (DBP) > 90 mmHg, or both affects approximately 1.28 billion people aged between 30 and 79 years globally [1, 2]. The overall global prevalence of hypertension in 2000 was estimated at 26.4% [3]. In the 2015 estimates, however, the average prevalence had increased to 32.3% in low- and middle-income countries, with prevalence estimates of 39.1% in the Latin American and Caribbean regions [4]. Interestingly, the prevalence of hypertension was also reportedly the highest in populations from the upper middle-income countries (37.8%) and lowest in populations from low-income countries (23.1%) [4]. In addition, prevalence estimates were higher in those aged 65 years and above compared with that in those below 65 years of age. No significant gender-difference in hypertension prevalence was noted, but persons with no formal education (49.0%), or who were overweight/obese (46.4%), and urban settlers (32.7%) were more likely to be hypertensive compared with those who were educated, normal weight, and living in rural areas [4]. In Malaysia, the 2023 National Health and Morbidity Survey (NHMS, 2023) revealed that approximately one in three adults in Malaysia have hypertension [5]. Faculty of Medicine 2024-09 Article PeerReviewed text en https://ir.uitm.edu.my/id/eprint/101434/1/101434.pdf Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor. (2024) Journal of Clinical and Health Sciences (JCHS) <https://ir.uitm.edu.my/view/publication/Journal_of_Clinical_and_Health_Sciences_=28JCHS=29/>, 9 (2). pp. 1-8. ISSN 0127-984X https://jchs-medicine.uitm.edu.my/
spellingShingle Hypertension
Peng, Hoh-Boon
Ibrahim, Fananta
Maamor, Nur Hasnah
Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor
title Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor
title_full Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor
title_fullStr Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor
title_full_unstemmed Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor
title_short Precision medicine in hypertension: are we there? / Hoh-Boon-Peng, Fananta Ibrahim and Nur Hasnah Maamor
title_sort precision medicine in hypertension: are we there? / hoh-boon-peng, fananta ibrahim and nur hasnah maamor
topic Hypertension
url https://ir.uitm.edu.my/id/eprint/101434/1/101434.pdf
https://ir.uitm.edu.my/id/eprint/101434/
https://jchs-medicine.uitm.edu.my/
url_provider http://ir.uitm.edu.my/